Equities research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for shares of Aligos Therapeutics in a report issued on Tuesday, March 11th. HC Wainwright analyst E.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback